Digitization and networking are the central development concepts of production in the sense of Industrie 4.0. For manufacturing pharmaceutical companies, these modernizations result in significant market advantages: One is that powerful systems for obtaining and evaluating process and product data in real time provide valuable information that can be used for optimization. Additionally, they facilitate compliance with regulatory requirements - from Good Manufacturing Practice (GMP) to EU directives on serialization and anti-counterfeiting.
Furthermore, process chains can be organized more agile through digitization and networking. This results in a new level of flexibility that prepares pharmaceutical manufacturers for the challenges of the personalized medicine of the future.
The modernization and development of production processes and process chains according to Industrie 4.0 is a core competence of the Fraunhofer IPT: Together with you, we develop individual solution concepts for the establishment of new technologies as well as for networking and adaptive design of production in your company.